Generic placeholder image

Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

ISSN (Print): 1568-007X
ISSN (Online): 1568-007X

5-HT4 Receptors

Author(s): J Bockaert, S Claeysen, V Compan and A Dumuis

Volume 3, Issue 1, 2004

Page: [39 - 51] Pages: 13

DOI: 10.2174/1568007043482615

Price: $65

Abstract

Serotonin 4 receptors (5-HT4Rs) were discovered 15 years ago. They are codedby a very complex gene (700Kb, 38 exons) which generates eight carboxy-terminalvariants (a, b, c, d, e, f, g, n). Their sequences differ after position L358. Another variant ischaracterized by a 14 residue insertion within the extracellular loop 2. Highly selectivepotent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studiesis still missing. Based on physiological and behavioral experiments, 5-HT4Rs may be targets to treatcognitive deficits, abdominal pain and feeding disorders. One 5-HT4R-directed drug(SL65.0155) is already in phase II to treat patients suffering from memory deficits ordementia.

Keywords: 5-ht4 receptors, splice variants, g proteins, neurotransmitter release, cognition, pain, anxiety, feeding, cns drug targets


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy